← Leaderboards
Naomi B Haas
University Of Pennsylvania
$989,767
Attributed
$2,444,995
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $468.2K · FY2018–25$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,444,995 · 3
By mechanism
R01$2,182,842 · 1
R50$178,893 · 1
P30$83,260 · 1
Top collaborators
- Peter Celestine Hollenhorst5 shared
- Roberto Pili5 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- M. Celeste Simon$38,172,459
- Ravi K Amaravadi$13,477,656
- Wendy K Rathmell$9,818,166
- Warren S Pear$28,448,095
- Nicola J Mason$7,580,948
Others in their field
Other Emerging Leaders on “Translating”
- Leonard Freedman · Leidos Biomedical Research, Inc.$362,430,297
- Lynn Briscoe · Leidos Biomedical Research, Inc.$130,241,827
- Leonard Freedmand · Leidos Biomedical Research, Inc.$95,252,769
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Bambra Strokes · Ppd Development Lp$65,000,267
- Klaus Romero · Critical Path Institute$56,862,776
Research focus
TranslatingInnovationResponseChromatinEpigenetic ProcessMalignant Neoplasm Of ProstateMolecularResistanceSamplingTumorResponse BiomarkerClinical DataRenal Cell CarcinomaRenal CarcinomaDetectionAntitumor EffectEzh2 GeneClear Cell Renal Cell CarcinomaClinical ManagementHistone MethyltransferaseChip-SeqChromatin RemodelingAcquired Drug ResistanceEnhancers
Grant awards (7)
Engaging Impactful Immunotherapy Approaches in Renal Cell Cancer Studies$178,893
R50 · FY2025 · CA · contact PI
Cancer Therapeutics Program$83,260
P30 · FY2024 · CA · contact PI
Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma$429,896
R01 · FY2022 · CA
Epigenetic Mechanisms of Drug Resistance in Renal Cell Carcinoma$468,240
R01 · FY2021 · CA
Epigenetic mechanisms of drug resistance in renal cell carcinoma$406,936
R01 · FY2020 · CA
Epigenetic mechanisms of drug resistance in renal cell carcinoma$417,407
R01 · FY2019 · CA
Epigenetic mechanisms of drug resistance in renal cell carcinoma$460,363
R01 · FY2018 · CA